NURIX THERAPEUTICS INC (NRIX) Stock Cash Flow
NASDAQ:NRIX - Nasdaq - US67080M1036 - Common Stock - Currency: USD
| TTM (2025-2-28) | 2024 (2024-11-30) | 2023 (2023-11-30) | 2022 (2022-11-30) | 2021 (2021-11-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -208.40M | -193.57M | -143.95M | -180.36M | -117.19M | |||
| Depreciation Amortization | 18.51M | 16.43M | 13.65M | 5.35M | 2.79M | |||
| Change In Working Capital | -22.22M | -18.40M | 20.12M | -19.02M | 9.11M | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 480.00K | |||
| Other non cash items | 20.39M | 22.96M | 28.81M | 34.23M | 20.93M | |||
| OPERATING CASH FLOW | -191.72M | -172.58M | -81.36M | -159.81M | -84.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -9.87M | -9.27M | -8.40M | -12.24M | -5.66M | |||
| Other Investing Activity | -257.82M | -248.44M | 76.70M | 39.44M | -102.59M | |||
| INVESTING CASH FLOW | -267.69M | -257.71M | 68.30M | 27.20M | -108.25M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 485.52M | 485.67M | 3.22M | 117.19M | 153.88M | |||
| FINANCING CASH FLOW | 485.52M | 485.67M | 3.22M | 117.19M | 153.88M | |||
| CHANGE IN CASH | 26.10M | 55.37M | -9.85M | -15.42M | -38.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -191.72M | -172.58M | -81.36M | -159.81M | -84.37M | |||
| Capital Expenditure | -9.87M | -9.27M | -8.40M | -12.24M | -5.66M | |||
| FREE CASH FLOW | -201.59M | -181.86M | -89.77M | -172.05M | -90.03M | |||
All data in USD